Cited by 86Antifungal resistance and susceptibilityFungal and yeast genetics researchYeasts and Rust Fungi Studies

Changes in Karyotype and Azole Susceptibility of Sequential Bloodstream Isolates from Patients with Candida glabrata Candidemia

Open access
Shin, Jong Hee, Chae, Myung Jong, Song, Jeong Won, Jung, Sook-In, Cho, Duck, Kee, Seung Jung, Kim, Soo Hyun, Shin, Myung Geun +2 more·2007·Journal of Clinical Microbiology

Abstract

We examined the changes in genotypes and azole susceptibilities among sequential bloodstream isolates of Candida glabrata during the course of fungemia and the relationship of these changes to antifungal therapy. Forty-one isolates were obtained from 15 patients (9 patients who received antifungal therapy and 6 patients who did not) over periods of up to 36 days. The isolates were analyzed using pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) and tested for antifungal susceptibility to fluconazole, itraconazole, and voriconazole. PFGE typing consisted of electrophoretic karyotyping and restriction endonuclease analysis of genomic DNA by use of NotI (REAG-N). The 41 isolates yielded 23 different karyotypes and 11 different REAG-N patterns but only 3 MLST types. The sequential strains from each patient had identical or similar REAG-N patterns. However, they had two or three different karyotypes in 6 (40%) of 15 patients. The isolates from these six patients exhibited the same or similar azole susceptibilities, and five patients did not receive antifungal therapy. Development of acquired azole resistance in sequential isolates was detected for only one patient. For this patient, an isolate of the same genotype obtained after azole therapy showed three- or fourfold increases in the MICs of all three azole antifungals and exhibited increased expression of the CgCDR1 efflux pump. This study shows that karyotypic changes can develop rapidly among sequential bloodstream strains of C. glabrata from the same patient without antifungal therapy. In addition, we confirmed that C. glabrata could acquire azole resistance during the course of fungemia in association with azole therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jcm.00381-07

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • C. glabrata can undergo genomic re-arrangements as an adaptive survival mechanism.

    “Previous studies found that C. glabrata can undergo genomic re-arrangements as an adaptive survival mechanism (Shin et al., 2007; Muller et al., 2009; Poláková et al., 2009).”
  • The C. glabrata genome shows plasticity, and alterations in karyotype and chromosome size have been observed in clinical isolates and the reference strain CBS138.

    “The C. glabrata genome shows plasticity, and alterations in karyotype and chromosome size have been observed in clinical isolates and the reference strain CBS138 [19,20,21].”

    From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [19]

  • Genome plasticity has been connected with antifungal drug resistance in C. glabrata.

    “Since genome plasticity has been connected with antifungal drug resistance in C. glabrata (Shin et al., 2007; Polakova et al., 2009)”

    From Genetic Drivers of Multidrug Resistance in Candida glabrata (2016) · cites this paper as Shin et al., 2007

  • Candida glabrata has been frequently reported as exhibiting variable karyotypes between isolates.

    “C. glabrata has been frequently reported as exhibiting variable karyotypes between isolates [57,58,59,60,61,62,63,64]”

    From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [64]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 28 · Cited by 86

Research works printed but not linked: 1

  1. [9]Dodgson, A. R., C. Pujol, D. W. Denning, D. R. Soll, and A. J. Fox. 2003. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J. Clin. Microbiol. 41:5709-5717. [DOI] [PMC free article] [PubMed] [Google Scholar]

Authors
Shin, J. H., Chae, M. J., Song, J. W., Jung, S.-I., Cho, D., Kee, S. J., Kim, S. H., Shin, M. G., Suh, S. P., & Ryang, D. W.
Affiliations
  • Departments of Laboratory Medicine
  • Chonnam National University (KR)
Corresponding author
Shin, Jong Hee
Venue
Journal of Clinical Microbiology
Published
2007-08
Volume
45
Issue
8
Pages
2385-2391
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W2156441608
Cited by
86
References
28
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 3 · 2021: 5 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 3 · 2016: 6 · 2015: 4 · 2014: 9 · 2013: 6 · 2012: 5
FWCI
3.36
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Microbiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Chonnam National University
  • Terveyden ja hyvinvoinnin laitos
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
Keywords
Candida glabrata, candidemia, fungemia, karyotype changes, azole resistance, antifungal therapy, fluconazole, itraconazole, voriconazole, multilocus sequence typing, pulsed-field gel electrophoresis, genotypic variation
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Antifungal Agents, Azoles, Candidiasis, Child, Preschool, DNA, Fungal, Female, Genotype, Humans, Karyotyping, Longitudinal Studies, Male, Microbial Sensitivity Tests, Middle Aged, Polymorphism, Restriction Fragment Length, Fungemia, Electrophoresis, Gel, Pulsed-Field, Mycological Typing Techniques, Sequence Analysis, DNA, ATP-Binding Cassette Transporters, Drug Resistance, Fungal, Candida glabrata

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review